Skip to main content
Clinical Trials/NCT05972070
NCT05972070
Recruiting
N/A

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

ROM Technologies, INC1 site in 1 country500 target enrollmentJune 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
ROM Technologies, INC
Enrollment
500
Locations
1
Primary Endpoint
Session attended
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco cessation, lipid, blood pressure, and psychosocial management. These tasks will be accomplished through concurrent conversations between patients and their therapist's utilizing telemedicine with observed exercise training.

Detailed Description

The focus of this study is to determine the feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. The study consists of an initial review, rehabilitation sessions, nutrition consultation, and risk stratification. Once the patient is cleared for the rehabilitation program, they will be assigned a cardiac rehab specialist and begin the 36 rehabilitation sessions. The sessions include pre-session questions, surveys, pre-, during, and post vitals, exercise protocol, and off-the-device exercises.

Registry
clinicaltrials.gov
Start Date
June 1, 2023
End Date
December 31, 2025
Last Updated
9 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ROM Technologies, INC
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Over the age of 18
  • NYHA Functional Class I, II,
  • Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation)
  • Candidate for traditional center-based cardiac rehabilitation

Exclusion Criteria

  • Under the age of 18
  • Adults lacking capacity to consent.
  • NYHA Functional Class III, IV
  • Acute coronary syndrome
  • Systolic heart failure (LV EF \<40%)
  • Status post cardiac surgery for structural heart disease or heart transplant
  • Percutaneous coronary angioplasty
  • Adults lacking capacity to consent.
  • Pregnant women

Outcomes

Primary Outcomes

Session attended

Time Frame: 12 weeks (End of treatment)

Measure the number of sessions attended to determine the ease of patients to utilize home-based cardiac rehab integrated with telemedicine (non-inferiority to historical controls)

Duke Activity Status Index (DASI)

Time Frame: Baseline, 12 weeks (End of Treatment)

Estimate of functional capacity

Sessions completed

Time Frame: 12 weeks(End of treatment)

Measure the number of sessions completed to determine compliance of patients to utilize home-based cardiac rehab integrated with telemedicine

Short Physical Performance Battery

Time Frame: Baseline, 12 weeks (End of Treatment)

Lower extremity functional assessment

Patient Health Questionnaire(PHQ)

Time Frame: Baseline, 12 weeks (End of Treatment)

Quality of Life assessment

Short Form-36

Time Frame: Baseline, 12 weeks (End of Treatment)

Quality of Life assessment

Secondary Outcomes

  • Laboratory assessment(Baseline, 12 weeks (End of Treatment))

Study Sites (1)

Loading locations...

Similar Trials